title: High sensitivity of Giardia duodenalis to tetrahydrolipstatin (orlistat) in vitro.
abstract: Giardiasis, a gastrointestinal disease caused by Giardia duodenalis, is currently treated mainly with nitroimidazoles, primarily metronidazole (MTZ). Treatment failure rates of up to 20 percent reflect the compelling need for alternative treatment options. Here, we investigated whether orlistat, a drug approved to treat obesity, represents a potential therapeutic agent against giardiasis. We compared the growth inhibitory effects of orlistat and MTZ on a long-term in vitro culture adapted G. duodenalis strain, WB-C6, and on a new isolate, 14-03/F7, from a patient refractory to MTZ treatment using a resazurin assay. The giardiacidal concentration of the drugs and their combined in vitro efficacy was determined by median-effect analysis. Morphological changes after treatment were analysed by light and electron microscopy. Orlistat inhibited the in vitro growth of G. duodenalis at low micromolar concentrations, with isolate 14-03/F7 (IC50(24h) = 2.8 µM) being more sensitive than WB-C6 (IC50(24h) = 6.2 µM). The effect was significantly more potent compared to MTZ (IC50(24h) = 4.3 µM and 11.0 µM, respectively) and led to specific undulated morphological alterations on the parasite surface. The giardiacidal concentration of orlistat was >14 µM for 14-03/F7 and >43 µM for WB-C6, respectively. Importantly, the combination of both drugs revealed no interaction on their inhibitory effects. We demonstrate that orlistat is a potent inhibitor of G. duodenalis growth in vitro and kills parasites at concentrations achievable in the gut by approved treatment regimens for obesity. We therefore propose to investigate orlistat in controlled clinical studies as a new drug in giardiasis.
authors: Institute of Pharmacy, Pharmaceutical Biology, Freie Universität Berlin, Berlin, Germany.
authors: Juliane
authors: J
authors: Hahn
authors: Frank
authors: F
authors: Seeber
authors: Herbert
authors: H
authors: Kolodziej
authors: Ralf
authors: R
authors: Ignatius
authors: Michael
authors: M
authors: Laue
authors: Toni
authors: T
authors: Aebischer
authors: Christian
authors: C
authors: Klotz
mesh_terms: D016923:Cell Death / Q000187:drug effects; D004357:Drug Synergism; D016829:Giardia lamblia / Q000166:cytology / Q000187:drug effects* / Q000254:growth & development / Q000648:ultrastructure; D007783:Lactones / Q000494:pharmacology*; D008795:Metronidazole / Q000494:pharmacology; D000077403:Orlistat; D021261:Parasitic Sensitivity Tests; D053058:Trophozoites / Q000187:drug effects / Q000254:growth & development / Q000648:ultrastructure
chemical_list: D007783:Lactones; D008795:Metronidazole; D000077403:Orlistat
references: Science. 2011 Aug 5;333(6043):724-9
references: 21817045
references: Am J Trop Med Hyg. 2010 Jul;83(1):171-3
references: 20595497
references: Cancer Res. 2004 Mar 15;64(6):2070-5
references: 15026345
references: J Pediatr. 1986 Jun;108(6):1005-10
references: 3519912
references: Drug Saf. 2008;31(1):53-65
references: 18095746
references: Methods Mol Biol. 2011;731:421-34
references: 21516426
references: Parasitology. 2011 Mar;138(3):267-78
references: 20880419
references: PLoS Negl Trop Dis. 2009 Dec 01;3(12):e558
references: 19956662
references: Expert Opin Drug Saf. 2012 May;11(3):459-71
references: 22439841
references: Nat Rev Drug Discov. 2004 Aug;3(8):673-83
references: 15286734
references: Chemistry. 2012 Jul 2;18(27):8403-13
references: 22674877
references: J Antimicrob Chemother. 2011 May;66(5):1029-35
references: 21393225
references: Future Oncol. 2010 Apr;6(4):551-62
references: 20373869
references: J Parasitol. 2007 Oct;93(5):979-84
references: 18163329
references: Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3424-9
references: 20142509
references: J Med Chem. 2009 Jul 9;52(13):4038-53
references: 19480409
references: Biochem Pharmacol. 2013 Feb 1;85(3):439-47
references: 23228697
references: J Antimicrob Chemother. 2003 Apr;51(4):1017-20
references: 12654760
references: Int J Parasitol. 2002 Jun;32(6):655-75
references: 12062485
references: Methods Cell Biol. 2010;96:1-20
references: 20869516
references: Infect Disord Drug Targets. 2010 Aug;10(4):283-94
references: 20429863
references: J Clin Microbiol. 1981 Dec;14(6):709-10
references: 7037844
references: PLoS One. 2009;4(1):e4281
references: 19169353
references: Trans R Soc Trop Med Hyg. 1991 Jan-Feb;85(1):67-9
references: 2068765
references: J Antibiot (Tokyo). 1987 Aug;40(8):1081-5
references: 3680018
references: J Antimicrob Chemother. 2003 Jul;52(1):1
references: 12805255
references: Nat Rev Microbiol. 2010 Jun;8(6):413-22
references: 20400969
references: J Microbiol Methods. 2007 Nov;71(2):101-6
references: 17888535
references: Mol Microbiol. 2005 Aug;57(4):1113-26
references: 16091048
references: Parasitology. 2011 Sep;138(11):1354-61
references: 21819642
references: Adv Enzyme Regul. 1984;22:27-55
references: 6382953
references: Emerg Infect Dis. 2003 Nov;9(11):1444-52
references: 14718089
references: J Immunol. 2011 Oct 1;187(7):3769-75
references: 21873528
references: J Biol Chem. 1991 Feb 5;266(4):2021-7
references: 1899234
references: Clin Microbiol Rev. 2001 Jan;14(1):150-64
references: 11148007
references: Biochim Biophys Acta. 1988 Oct 14;962(3):308-16
references: 3167082
references: Microbiology (Reading). 2007 Dec;153(Pt 12):4150-4158
references: 18048928
references: Expert Opin Drug Saf. 2009 Nov;8(6):727-44
references: 19998527
references: Trends Parasitol. 2010 Feb;26(2):75-82
references: 20056486
references: Clin Microbiol Rev. 2001 Jan;14(1):114-28
references: 11148005
references: J Antimicrob Chemother. 2011 Aug;66(8):1756-65
references: 21602576
references: Exp Parasitol. 1999 May;92(1):1-11
references: 10329359
references: AIDS Res Hum Retroviruses. 2012 Sep;28(9):961-2
references: 22280308
references: Trans R Soc Trop Med Hyg. 1983;77(4):487-8
references: 6636276
references: Trends Parasitol. 2006 May;22(5):203-8
references: 16545611
references: Mol Biochem Parasitol. 1996 Aug;79(2):183-93
references: 8855555